Most Read Articles
Dr. Joseph Delano Fule Robles, 20 Dec 2016

Researchers from the US recently demonstrated synergistic effects of topical calcipotriol and 5-fluorouracil (5-FU) for the treatment of actinic keratosis, a known precursor to squamous cell carcinoma (SCC) of the skin. 

11 Nov 2016
Non-purulent cellulitis and cutaneous abscesses, despite both belonging to the spectrum of skin and soft-tissue infections, are aetiologically different, a new study reports. Further, atypical bacteria may be present in cellulitis patients, indicating novel disease mechanisms.
Audrey Abella, 19 Mar 2019
Long-term use of the humanized immunoglobulin G1K monoclonal antibody tildrakizumab generated durable responses in adult patients with moderate-to-severe chronic plaque psoriasis*, according to the results of the 3-year extension phases of reSURFACE 1** and 2*** presented at AAD 2019.

Podcast: Dr Michael Koren talks about the final report of the OSLER-1 study

21 Nov 2018
Podcast: Dr Michael Koren talks about the final report of the OSLER-1 study
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 20 Dec 2016

Researchers from the US recently demonstrated synergistic effects of topical calcipotriol and 5-fluorouracil (5-FU) for the treatment of actinic keratosis, a known precursor to squamous cell carcinoma (SCC) of the skin. 

11 Nov 2016
Non-purulent cellulitis and cutaneous abscesses, despite both belonging to the spectrum of skin and soft-tissue infections, are aetiologically different, a new study reports. Further, atypical bacteria may be present in cellulitis patients, indicating novel disease mechanisms.
Audrey Abella, 19 Mar 2019
Long-term use of the humanized immunoglobulin G1K monoclonal antibody tildrakizumab generated durable responses in adult patients with moderate-to-severe chronic plaque psoriasis*, according to the results of the 3-year extension phases of reSURFACE 1** and 2*** presented at AAD 2019.